CAR T-Cell Therapy Approval Starts New Path in Childhood Leukemia – OncLive
OncLive |
CAR T-Cell Therapy Approval Starts New Path in Childhood Leukemia
OncLive In an interview with OncLive, Sarah K. Tasian, MD, an attending physician in the Division of Oncology at Children's Hospital of Philadelphia, discussed the success of CAR T-cell therapy, as well as novel agents and immunotherapies that appear promising … |
